FDA
approval
· 2024-11-14
FDA Approved: DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for Diphenoxylate hydrochloride and atropine sulfate by Hikma Pharmaceuticals USA Inc., marking a modification to an alr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE (DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE)